aBeijing Key Laboratory of Cell & Gene Therapy for Solid Tumour, State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Department of Early Drug Development Centre, ...

Perovskite solar cells are a high-efficiency, low-cost alternative to traditional silicon-based solar panels. With the perovskite solar cell industry expected to reach $1.2 billion by 2033 ...

Tarlatamab, a bispecific delta-like ligand 3–directed T-cell engager immunotherapy, received accelerated approval for the treatment of patients with previously treated small-cell lung cancer.

B-cell lymphomas make up most (about 85%) of the non-Hodgkin lymphomas (NHL) in the United States. These types of lymphomas start in early forms of B lymphocytes (B cells). The most common types of ...

As reported in 2024, 10 we applied a combination of third-generation CD19.CAR-T cells, mycophenolate, and nintedanib in a single white patient with anti-Scl70 positive severe SSc and rapidly ...

A paradigm shift in the way we treat spinal injuries is now in sight, with the world's first regenerative cell therapy being granted approval for a registrational Phase I clinical trial.

Candid's T-cell engager shopping spree rolls on with WuXi Biologics pact worth up to $925M As for Juri, very little is publicly known about the TCG Labs Soleil-created company.

When Bruce Levine and his colleagues began attempting to engineer immune cells to fight cancer in the 1990s, few people thought they would succeed. “The wider community was very sceptical ...

1Laboratory of Tumor Inflammation and Angiogenesis, Center for Cancer Biology, VIB, Leuven, Belgium. 2Laboratory of Tumor Inflammation and Angiogenesis, Center for Cancer Biology, Department of ...

In this study, we explored the role of Grb2 in AP. Methods: We screened for gene affecting macrophage activation in AP by combining transcriptomics with Single-cell RNA-sequence analysis. Next, the ...

Researchers have developed a vascularized organoid model of hormone secreting cells in the pancreas. The advance promises to improve diabetes research and cell-based therapies. Researchers led by ...